Security guard develops allergic reaction after Covid vaccinations at AIIMS

A security guard who was administered a shot of Covaxin at AIIMS here was admitted at the hospital after he developed an allergic reaction as part of "severe" adverse events following immunisation

AIIMS
AIIMS. Photo: PTI
Press Trust of India New Delhi
2 min read Last Updated : Jan 16 2021 | 11:55 PM IST

A security guard who was administered a shot of Covaxin at AIIMS here on Saturday was admitted at the hospital after he developed an allergic reaction as part of "severe" adverse events following immunisation.

According to AIIMS Director Randeep Guleria, the security guard, in his 20s, at AIIMS who received the jab after 4 pm, complained of palpitations and developed an allergic skin rash within 15-20 minutes after being inoculated and was admitted to the facility.

"He was immediately managed with appropriate treatment and he improved. He is stable. As a precautionary measure he has been admitted for overnight observation and his condition is being monitored. He is likely to be discharged in the morning," Guleria said.

One "severe" and 51 "minor" cases of AEFI (adverse events following immunisation) were reported among healthcare workers who were administered the coronavirus vaccine in Delhi on the first day of the COVID-19 vaccination drive on Saturday, official figures showed.

Against a target of 8,117 health workers to be vaccinated on the first day of the drive in 11 districts of Delhi, a total of 4,319 were administered the vaccine, the figures showed.

Officials said a few cases of AEFI were observed in some people who were administered the vaccine.

"A few AEFI cases were reported but most were minor and the persons were normalised during observation period. Only one severe AEFI case was reported in South Delhi," said a top government official.

According to the World Health Organisation (WHO), any untoward medical occurrence which follows immunisation and does not necessarily have a causal relationship with the usage of the vaccine, is known as AEFI.

Eleven cases of "minor" AEFI were reported from south and southwest districts, showed official data.

The "minor" AEFI cases were reported from all districts except northeast and Shahdara districts, officials said.

Administration of coronavirus vaccine started in Delhi at 81 centres across the city on Saturday. Each Centre was targeted to administer vaccines to 100 people (health workers).

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAIIMSCoronavirus VaccineCoronavirus TestsDelhi

First Published: Jan 16 2021 | 11:40 PM IST

Next Story